Find clinical trials for COVID-19 in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near New York, NY, USA:
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
New York, New York, United States and 108 other locations
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Brooklyn, New York, United States and 123 other locations
This study is designed to demonstrate the performance and usability of the the Panbio™ COVID-19/Flu A&B Panel Self Test in the hand...
Brooklyn, New York, United States and 1 other location
A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...
Phase 2, Phase 3
Staten Island, New York, United States and 28 other locations
stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...
Bronx, New York, United States and 47 other locations
The primary objective of this study is to evaluate the safety and tolerability of intravenous (IV) IMM-BCP-01 in subjects with mild to moderate COVID...
Phase 1
New York, New York, United States and 2 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
New York, New York, United States and 217 other locations
an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in patients with moderate COVID...
Phase 1, Phase 2
Hackensack, New Jersey, United States and 6 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Hackensack, New Jersey, United States and 214 other locations
is to assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID...
Phase 2
Brooklyn, New York, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal